[go: up one dir, main page]

Garcia et al., 2006 - Google Patents

Synthesis and biological evaluation of tricarbonyl Re (I) and Tc (I) complexes anchored by poly (azolyl) borates: application on the design of radiopharmaceuticals for …

Garcia et al., 2006

View PDF
Document ID
3995020611008665620
Author
Garcia R
Gano L
Maria L
Paulo A
Santos I
Spies H
Publication year
Publication venue
JBIC Journal of Biological Inorganic Chemistry

External Links

Snippet

The building blocks fac-[99mTc {κ3-HB (timMe) 3}(CO) 3] and fac-[99mTc {κ3-R (μ-H) B (timMe) 2}(CO) 3][R is H (4a), Ph (5a); timMe is 2-mercapto-1-methylimidazolyl] were obtained almost quantitatively by reacting fac-[99mTc (CO) 3 (H2O) 3]+ with the …
Continue reading at projects.ctn.tecnico.ulisboa.pt (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/0474—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/0493—Steroids, e.g. cholesterol, testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/041—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic System
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds; Labelled organic compounds per se
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Similar Documents

Publication Publication Date Title
Comba et al. Octadentate Picolinic Acid‐Based Bispidine Ligand for Radiometal Ions
KR102850587B1 (en) Prostate-specific membrane antigen-binding dual-mode radiotracer and therapeutics
Banerjee et al. Bifunctional Single Amino Acid Chelates for Labeling of Biomolecules with the {Tc (CO) 3}+ and {Re (CO) 3}+ Cores. Crystal and Molecular Structures of [ReBr (CO) 3 (H2NCH2C5H4N)],[Re (CO) 3 {(C5H4NCH2) 2NH}] Br,[Re (CO) 3 {(C5H4NCH2) 2NCH2CO2H}] Br,[Re (CO) 3 {X (Y) NCH2CO2CH2CH3}] Br (X= Y= 2-pyridylmethyl; X= 2-pyridylmethyl, Y= 2-(1-methylimidazolyl) methyl; X= Y= 2-(1-methylimidazolyl) methyl),[ReBr (CO) 3 {(C5H4NCH2) NH (CH2C4H3S)}], and [Re (CO) 3 {(C5H4NCH2) N (CH2C4H3S)(CH2CO2)}]
US7250525B2 (en) Stilbene derivatives and their use for binding and imaging amyloid plaques
Iovkova et al. para‐Functionalized Aryl‐di‐tert‐butylfluorosilanes as Potential Labeling Synthons for 18F Radiopharmaceuticals
Garcia et al. Synthesis and biological evaluation of tricarbonyl Re (I) and Tc (I) complexes anchored by poly (azolyl) borates: application on the design of radiopharmaceuticals for the targeting of 5-HT1A receptors
AU2002323417A1 (en) Stilbene derivatives and their use for binding and imaging amyloid plaques
Chen et al. The syntheses and structures of ‘3+ 2’and ‘2+ 2+ 1’oxorhenium mixed-ligand complexes employing 8-hydroxy-5-nitroquinoline as the bidentate N, O donor ligand
Cai et al. Synthesis of a novel bifunctional chelator AmBaSar based on sarcophagine for peptide conjugation and 64Cu radiolabelling
WO2008023780A1 (en) Method of rapid methylation, kit for preparing pet tracer and method of producing pet tracer
WO2010053218A1 (en) Fluorinated benzothiazole derivatives, preparation method thereof and imaging agent for diagnosing altzheimer's disease using the same
NZ577458A (en) Acetylene derivatives and their use for binding and imaging amyloid plaques
Benoist et al. A Click procedure with heterogeneous copper to tether technetium-99m chelating agents and rhenium complexes. Evaluation of the chelating properties and biodistribution of the new radiolabelled glucose conjugates
Louie et al. Preparation, characterization, and screening of a high affinity organometallic probe for α-adrenergic receptors
Pena-Bonhome et al. Toward 68Ga and 64Cu Positron Emission Tomography Probes: Is H2dedpa-N, N′-pram the Missing Link for dedpa Conjugation?
Mindt et al. Molecular assembly of multifunctional 99mTc radiopharmaceuticals using “clickable” amino acid derivatives
Zenati et al. Synthesis and biological evaluation of 99mTc labeled aryl piperazine derivatives as cerebral radiotracers
US7658910B2 (en) Preparation of radiolabelled haloaromatics via polymer-bound intermediates
Kothari et al. Syntheses, in vitro and in vivo characterization of a 99mTc-(I)-tricarbonyl-benzylamino-dihydroxymethyl phosphine (NP2) chelate
Hassanzadeh et al. 2‐Amino‐3‐(1‐(4‐(4‐(2‐methoxyphenyl) piperazine‐1‐yl) butyl)‐1H‐1, 2, 3‐triazol‐4‐yl) propanoic acid: synthesized, 99mTc‐tricarbonyl labeled, and bioevaluated as a potential 5HT1A receptor ligand
Palma et al. Rhenium and technetium tricarbonyl complexes anchored by 5-HT1A receptor-binding ligands containing P, O/N donor atom sets
Satpati et al. Preparation and bioevaluation of 99mTc-carbonyl complex of 5-hydroxy tryptamine derivative
Silva et al. Chemical, radiochemical and biological studies of new gallium (III) complexes with hexadentate chelators
Yang et al. Synthesis and evaluation of 111In-labeled D-glucose as a potential SPECT imaging agent
Hierlmeier et al. Radiochemistry and Complex Formation of the Cyclen-Derived Chelator DOTI-Me with Mn2+, Cu2+, Zn2+, Ga3+, In3+, Tb3+, and Lu3+